ABSTRACT
OBJECTIVE:To evaluated the utilization of antineoplastics for intravenous use in our hospital and to provide references for clinical medication and pharmacoeconomic research. METHODS:The utilization of antineoplastics in our hospital from 2007 to 2009 was statistically analyzed in respect of consumption sum and DDDs. RESULTS:Amount and consumption sum of antineoplastics in our hospital increased rapidly in recent 3 years. The DDDs of drug were markedly different from their consumption sum rank,for example Docetaxel injection. Antineoplastics for intravenous use sourcing from plants took up big proportion of antineoplastics and they accounted for 50% of the top 10 antineoplastics in the list of consumption sum. CONCLUSION:The antineoplastics for intravenous use in our hospital basically remain stable in category and develop rapidly in recent years,which focus on reasonable price,exact therapeutic effect and less adverse reaction.